Evidence map›Paper›PMID 39168619›Full record

ArticleIndustrial health2025

Development of the occupational stress scale for small and medium-sized enterprise owners for stress prevention measures.

Sumiko Kurioka, Akihito Hagihara, Katsuyuki Kamei, Masakazu Horikoshi, Olivier Torres

Abstract read
In one paragraph

Article in Industrial health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sumiko KuriokaDepartment of Health Policy and Management, University of Occupational and Environmental Health, Japan.
Akihito HagiharaNational Cerebral and Cardiovascular Center, Japan.
Katsuyuki KameiFaculty of Societal Safety Sciences, Kansai University, Japan.
Masakazu HorikoshiDepartment of Business Administration, Fukuyama Heisei University, Japan.
Olivier TorresMontpellier Management-LABEX Entreprendre, University of Montpellier, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Small and medium-sized enterprise (SME) owners are at an increased risk of mental disorders in addition to stress directly related to their business performance. However, steps to protect SME owners' mental health are lacking, and no occupational stress scale has been developed to accurately understand the real-world situation. Based on a nationwide internet survey of 1,000 Japanese SME owners aged 20-79 yr with five or more employees, we developed a novel occupational stress scale for SME owners. The 43-item scale assesses job stress factors and modifying factors (individual, non-work, and buffering factors). The validity and reliability of the scale were verified. The job stress factors were unique among SME owners and differed from those of employees, with moderate positive correlations with both psychological distress and presenteeism. Further, the study revealed the roles of modifying factors; work-family conflict increased presenteeism and psychological distress, while self-care and social support decreased them. The findings provide important insights for assessing psychological stress among SME owners, informing future mental health intervention strategies among this population.

Indexed as

Occupational StressSmall BusinessAdultAgedFemaleHumansJapanMaleMiddle AgedPresenteeismReproducibility of ResultsSocial SupportSurveys and QuestionnairesYoung AdultConsensus-based standards for the selection of health status measurement instruments (COSMIN)Occupational stressPresenteeismScale developmentSmall and medium-sized enterprise (SME) owners

Identifiers

PMID39168619
PMCPMC11995155

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.